Olink Holding Ab Publ Receivables Turnover Ratio (OLK), from the fourth quarter 2023 to the fourth quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Olink Holding Ab publ   (NASDAQ: OLK)
 

Olink Holding Ab Publ Accounts Receivables Turnover Ratio from the fourth quarter 2023 to the fourth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Olink Holding Ab Publ 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 2.7, above the company average. This is a clear sign of healthy business climate in the Laboratory Analytical Instruments industry and improving liquidity at their respective customers, during the fourth quarter 2023. Average receivable collection period, for the Olink Holding Ab Publ in Dec 31 2023 quarter, has decreased to 135 days, compared to 157 days, in the 0 quarter.

If we take a look into Healthcare sector 413 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from 2560 to 2950.

What is Receivable Turnover Ratio?
What is Olink Holding Ab Publ Selling?


What is Receivable Turnover Ratio?





OLK Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Receivable Change 19.06 % 19.06 % 19.06 % 19.06 % 25.4 %
Y / Y Revenue Change 21.18 % - - - 47.25 %
Receivable Turnover Ratio (TTM) 2.7 2.32 2.42 2.53 2.65
OLK's Total Ranking # 2950 # 2560 # 2894 # 0 # 3947
Accounts Receivable average collection period days 135 157 151 144 138
Seq. Receivable Change 0 % 0 % 0 % 19.06 % 0 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 14
Healthcare Sector # 414
Overall Market # 2950

Receivable Turnover Ratio Statistics
High Average Low
0.29 0.25 0.18
(Dec 31 2022)   (Dec 31 2021)






Financial Statements
Olink Holding Ab Publ 's Accounts Receivable $ 63 Millions Visit OLK's Balance sheet
Olink Holding Ab Publ 's Sales TTM $ 169 Millions Visit OLK's Income Statement
Sources of OLK's Revenues Visit OLK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OLK's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OLK's Growth Rates OLK's Roa OLK's Inventory Turnover Ratio OLK's Dividend Comparisons
OLK's Profitability Ratios OLK's Roi OLK's Asset Turnover Ratio OLK's Dividend Growth
OLK's Valuation Ratios OLK's Roe OLK's Financial Strength Ratios OLK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Amedisys Inc  7.42 $ 2,236.382  Millions$ 301.465  Millions
Shockwave Medical Inc   7.41 $ 729.842  Millions$ 98.560  Millions
Cardiff Oncology Inc   7.38 $ 3.549  Millions$ 0.481  Millions
Sotera Health Company  7.35 $ 1,049.158  Millions$ 142.796  Millions
Encision Inc   7.27 $ 6.867  Millions$ 0.945  Millions
Intuitive Surgical Inc   7.26 $ 7,123.500  Millions$ 980.600  Millions
Pediatrix Medical Group Inc   7.26 $ 1,994.640  Millions$ 274.814  Millions
Inhibikase Therapeutics Inc   7.23 $ 0.261  Millions$ 0.036  Millions
Strata Skin Sciences Inc  7.17 $ 31.528  Millions$ 4.396  Millions
Haemonetics Corporation  7.16 $ 1,269.891  Millions$ 177.412  Millions
Evolus Inc   7.13 $ 202.085  Millions$ 28.361  Millions
Hca Healthcare Inc   7.12 $ 64,968.000  Millions$ 9,127.500  Millions
Inovio Pharmaceuticals Inc   7.11 $ 8.965  Millions$ 1.260  Millions
Tenet Healthcare Corp  7.08 $ 20,548.000  Millions$ 2,902.000  Millions
Tela Bio Inc   7.06 $ 57.112  Millions$ 8.089  Millions
Durect Corp  7.05 $ 8.548  Millions$ 1.212  Millions
Elutia Inc   7.02 $ 34.746  Millions$ 4.949  Millions
The Oncology Institute Inc   7.01 $ 324.239  Millions$ 46.274  Millions
Teleflex Incorporated  6.96 $ 2,973.931  Millions$ 426.998  Millions
Prestige Consumer Healthcare Inc   6.96 $ 1,132.500  Millions$ 162.610  Millions
Tvardi Therapeutics Inc   6.96 $ 20.968  Millions$ 3.014  Millions
Lakeland Industries Inc   6.93 $ 124.688  Millions$ 17.983  Millions
Select Medical Holdings Corp  6.93 $ 6,664.058  Millions$ 961.627  Millions
Iridex Corp  6.90 $ 51.807  Millions$ 7.503  Millions
Pulmonx Corporation  6.89 $ 67.752  Millions$ 9.827  Millions
Axogen inc   6.89 $ 159.012  Millions$ 23.065  Millions
Ethema Health Corporation   6.86 $ 5.345  Millions$ 0.779  Millions
Pacira Biosciences inc   6.83 $ 674.978  Millions$ 98.799  Millions
Harvard Bioscience Inc   6.82 $ 112.071  Millions$ 16.431  Millions
Aurinia Pharmaceuticals Inc   6.82 $ 175.513  Millions$ 25.745  Millions

Date modified: 2026-09-08T15:11:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.